Prokarium Alternatives & Competitors
12 companies similar to Prokarium — LIVING CURES
Companies similar to Prokarium
Xilio Therapeutics, Inc.
Focused on harnessing the immune system to achieve deep and durable clinical responses to...
Bolt Biotherapeutics, Inc.
Plans to develop a novel format for T-cell mediated anti-tumour therapy
Macomics
Macrophage Biology Revealed:Developing breakthrough approaches to macrophage activity to c...
Brenus Pharma
Next-generation cancer treatment bringing the immune system one step ahead of cancer 🧬🟣
Rival Readout
Competing with Prokarium? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
IO Biotech
Break Boundaries. Ignite Change.
Persephone Biosciences
We are a synthetic biology company developing a platform to industrialize and scale the mi...
Elicio Therapeutics
Lymph-Node Targeted Immunotherapies
Tollys
A new dimension in immuno-oncology
Glycyx
Restoring immune response in cancer: reversing Opioid-Induced Immunodeficiency to enhance...
Alumis
Transforming the lives of patients living with immune-mediated diseases using a precision...
Apexigen
Creating Transformative Immunotherapies for Patients with Cancer
Virogin Biotech
Virotherapy to Ignite Immunotherapy
About Prokarium
Prokarium, founded in 2012 and headquartered in the United Kingdom, is carving a niche in the innovative field of microbial immunotherapy. With the slogan "LIVING CURES," the company is developing cutting-edge treatments that harness recent advances in cancer immunology to revolutionize immuno-oncology. Their lead prog...
Development of novel immunotherapies, Research and development of bacterial-based treatments for cancer, Discovery and clinical trial activities
Pharmaceutical companies, Biotechnology firms, Oncology researchers, Cancer treatment centers
Microbial Immunotherapy, Immuno-Oncology, Bladder Cancer Treatment, Cancer Immunology, Biopharmaceutical, Synthetic Biology, Vaccine Development, Oral Delivery Systems, Immune-Driven Antitumor Effects, Oncology Therapeutics, Cancer Treatment Paradigm, Long-Lasting Immunotherapy, Re-engineered Evolution, Cancer Immunotherapy, Biotechnology Platform
B2B, B2D, B2G
Licensing, Product Sales, Performance Based
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Prokarium: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Prokarium on 15 Jun 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.